Pain associated with COVID-19 vaccination is unrelated to skin biopsy abnormalities.
COVID-19 vaccination
Fibromyalgia
Quantitative sensory testing
Skin biopsy
Small-fibre neuropathy
Journal
Pain reports
ISSN: 2471-2531
Titre abrégé: Pain Rep
Pays: United States
ID NLM: 101683899
Informations de publication
Date de publication:
Sep 2023
Sep 2023
Historique:
received:
18
12
2022
revised:
07
04
2023
accepted:
05
05
2023
medline:
16
1
2024
pubmed:
16
1
2024
entrez:
16
1
2024
Statut:
epublish
Résumé
Previous clinical observations raised the possibility that COVID-19 vaccination might trigger a small-fibre neuropathy. In this uncontrolled observational study, we aimed to identify small fibre damage in patients complaining of generalized sensory symptoms and pain after COVID-19 vaccination. We collected clinical data, including a questionnaire for assessing autonomic symptoms (Composite Autonomic Symptom Score-31), and investigated quantitative sensory testing (QST) and skin biopsy in 15 prospectively enrolled patients with generalized sensory symptoms and pain after COVID-19 vaccination. Nine patients complaining of orthostatic intolerance also underwent cardiovascular autonomic tests. We found that all patients experienced widespread pain, and most of them (11 of 15) had a fibromyalgia syndrome. All patients had normal skin biopsy findings, and in the 9 patients with orthostatic intolerance, cardiovascular autonomic tests showed normal findings. Nevertheless, 5 patients had cold and warm detection abnormalities at the QST investigation. In our study, most patients complaining of generalized sensory symptoms and pain after COVID-19 vaccination had clinical and diagnostic test findings compatible with a fibromyalgia syndrome. Although the abnormal QST findings we found in 5 patients might be compatible with a small-fibre neuropathy, they should be cautiously interpreted given the psychophysical characteristics of this diagnostic test. Further larger controlled studies are needed to define precisely the association between small fibre damage and COVID-19 vaccination.
Identifiants
pubmed: 38225959
doi: 10.1097/PR9.0000000000001089
pii: PAINREPORTS-D-22-0154
pmc: PMC10789449
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e1089Informations de copyright
Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The International Association for the Study of Pain.
Déclaration de conflit d'intérêts
A. Truini received consulting fees or payment for lectures from Angelini, Grunenthal, Viatris. The other authors have no conflicts to declare.Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.